3,4-Seco-3,4-epoxyfriedelane-3-one - Names and Identifiers
Name | 3,4-Seco-3,4-epoxyfriedelane-3-one
|
Synonyms | Friedelalactone Friedelin 3,4-lactone 3,4-Seco-3,4-epoxyfriedelane-3-one 4-Hydroxy-3,4-secofriedelane-3-oic acid 3,4-lactone Chryseno[2,1-c]oxepin-3(2H)-one, eicosahydro-5,5a,7b,9a,12,12,13b,15a-octamethyl-, (5R,5aS,7aS,7bR,9aR,13aR,13bS,15aR,15bS)-
|
CAS | 29621-75-8
|
3,4-Seco-3,4-epoxyfriedelane-3-one - Physico-chemical Properties
Molecular Formula | C30H50O2
|
Molar Mass | 442.72 |
Storage Condition | 2-8℃ |
3,4-Seco-3,4-epoxyfriedelane-3-one - Introduction
3,4-seco-3, 4-epoxyfriedelane-3-one, referred to as 3,4-seco-epof, is a natural product that belongs to the class of terpenoids. It has some of the following properties:
1. Appearance: 3,4-seco-epof is a colorless crystalline solid.
2. Melting point: Its melting point is about 160-162 degrees Celsius.
3. Solubility: 3,4-seco-epof has good solubility in common organic solvents such as ethanol, dimethyl sulfoxide, etc.
This compound also has a number of important uses:
1. Drug research: 3,4-seco-epof has potential application value in drug research, such as the development of anti-cancer drugs.
2. Biological activity study: The compound has certain biological activity and can be used to study its effect on organisms and mechanism of action.
Regarding the preparation method, due to the confidentiality and patent issues involved, the general synthesis method is not easy to obtain. In general, however, the methods for obtaining such compounds usually involve structural modifications to the natural product and the selection of synthetic steps.
When using, you need to pay attention to the safety information of 3,4-seco-epof:
1. 3,4-seco-epof may be toxic, so it is necessary to follow appropriate laboratory safety practices and use personal protective equipment when operating.
2. The compound should be kept away from fire and oxidizing agents to prevent fire and explosion.
3. In the use or storage process, should strictly control the exposure and avoid direct contact.
Last Update:2024-04-09 21:54:55